Abstract Background and Aims We evaluated the efficacy safety of eculizumab in comparison with plasmapheresis intravenous immunoglobulin therapy renal transplant recipients diagnosed antibody-mediated rejection (AMR). Method This was a multicenter, open-label, prospective, randomized analysis. The patients were by type (eg, infusions or standard care [SOC]: plasmapheresis/intravenous immunoglob...